Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2014

01-08-2014 | Research Article

Effectiveness of a community pharmacy weight management programme

Authors: Helen F. Boardman, Anthony J. Avery

Published in: International Journal of Clinical Pharmacy | Issue 4/2014

Login to get access

Abstract

Background Obesity is a growing problem in England with one quarter of the adult population being obese and around 60 % being overweight or obese. Given the high costs of treating obesity-related conditions such as coronary heart disease and type-2 diabetes the UK Government aims to reduce obesity through public health services including those provided by community pharmacists. Objective To evaluate the effectiveness of a community pharmacy weight management clinic in assisting obese patients to reduce their weight. Setting Community pharmacies across four Primary Care Trusts in England. Methods Retrospective analysis of data collected by pharmacies providing weight management programmes. The service involved measurement with provision of advice and support. Data analysis consisted of frequency counts, percentages and means with standard deviations (SD) for demographic and biometric variables. Paired t tests were used to compare weight, waist circumference and blood pressure at 3 and 6 months. Main outcome measure Weight change at 3 months. Results 281 patients attended the programme across four Primary Care Trusts. Three-quarters were female, mean age 52.8 years (SD ± 14.4) and mean baseline weight 96.3 kg (SD ± 15.7). At 3 months patients had lost weight (mean change = −3.07 kg) and waist circumference (mean change = −3.87 cm), but there was no difference in blood pressure. After 6 months weight and waist circumference were further reduced from baseline (mean change = −4.59 kg, −4.79 cm respectively) and there was a reduction in blood pressure (mean change systolic = −9.5 mmHg; diastolic = −4.7 mmHg). Conclusion The study has demonstrated that reductions in weight and waist circumference can be achieved in patients who participate in a community pharmacy weight management programme.
Literature
3.
go back to reference Wolf H, Tuomilehto J, Kuulasmaa K, Domarkiene S, Cepaitis Z, Molarius A, et al. Blood pressure levels in the 41 populations of the WHO MONICA Project. J Hum Hypertens. 1997;11:733–42.PubMedCrossRef Wolf H, Tuomilehto J, Kuulasmaa K, Domarkiene S, Cepaitis Z, Molarius A, et al. Blood pressure levels in the 41 populations of the WHO MONICA Project. J Hum Hypertens. 1997;11:733–42.PubMedCrossRef
4.
go back to reference Cassano P, Segal M, Vokonas P, Weiss S. Body fat distribution, blood pressure, and hypertension. A prospective cohort study of men in the normative aging study. Ann Epidemiol. 1990;1:33–48.PubMedCrossRef Cassano P, Segal M, Vokonas P, Weiss S. Body fat distribution, blood pressure, and hypertension. A prospective cohort study of men in the normative aging study. Ann Epidemiol. 1990;1:33–48.PubMedCrossRef
5.
go back to reference Stevens J, Couper D, Pankow J, Folsom AR, Duncan BB, Nieto FJ, et al. Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. Obesity. 2001;9:696–705.CrossRef Stevens J, Couper D, Pankow J, Folsom AR, Duncan BB, Nieto FJ, et al. Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. Obesity. 2001;9:696–705.CrossRef
6.
8.
go back to reference Lang A. Froelicher ES: Management of overweight and obesity in adults: behavioral intervention for long-term weight loss and maintenance. Eur J Cardiovasc Nurs. 2006;5:102–14.PubMedCrossRef Lang A. Froelicher ES: Management of overweight and obesity in adults: behavioral intervention for long-term weight loss and maintenance. Eur J Cardiovasc Nurs. 2006;5:102–14.PubMedCrossRef
10.
go back to reference Hardcastle S, Taylor A, Bailey M, Castle R. A randomised controlled trial on the effectiveness of a primary health care based counselling intervention on physical activity, diet and CHD risk factors. Patient Educ Couns. 2008;70:31–9.PubMedCrossRef Hardcastle S, Taylor A, Bailey M, Castle R. A randomised controlled trial on the effectiveness of a primary health care based counselling intervention on physical activity, diet and CHD risk factors. Patient Educ Couns. 2008;70:31–9.PubMedCrossRef
11.
go back to reference Counterweight Project Team. Evaluation of the counterweight programme for obesity management in primary care: a starting point for continuous improvement. Br J Gen Pract. 2008;58:548–54.PubMedCentralCrossRef Counterweight Project Team. Evaluation of the counterweight programme for obesity management in primary care: a starting point for continuous improvement. Br J Gen Pract. 2008;58:548–54.PubMedCentralCrossRef
12.
13.
go back to reference Morrison D, McLoone P, Broshnahan N, McCombie L, Smith A, Gordon J. A community pharmacy weight management programme: an evaluation of effectiveness. BMC Public Health. 2013;13:282.PubMedCentralPubMedCrossRef Morrison D, McLoone P, Broshnahan N, McCombie L, Smith A, Gordon J. A community pharmacy weight management programme: an evaluation of effectiveness. BMC Public Health. 2013;13:282.PubMedCentralPubMedCrossRef
14.
go back to reference Blackburn G. Effect of degree of weight loss on health benefits. Obes Res. 1995;3(Suppl 2):211s–6s.PubMedCrossRef Blackburn G. Effect of degree of weight loss on health benefits. Obes Res. 1995;3(Suppl 2):211s–6s.PubMedCrossRef
15.
go back to reference Jolly K, Lewis A, Beach J, Denley J, Adab P, Deeks JJ, et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten up randomised controlled trial. BMJ. 2011;343:d6500.PubMedCentralPubMedCrossRef Jolly K, Lewis A, Beach J, Denley J, Adab P, Deeks JJ, et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten up randomised controlled trial. BMJ. 2011;343:d6500.PubMedCentralPubMedCrossRef
16.
go back to reference Counterweight Project Team. The implementation of the Counterweight Programme in Scotland, UK. Fam Pract. 2012;29:139–44.CrossRef Counterweight Project Team. The implementation of the Counterweight Programme in Scotland, UK. Fam Pract. 2012;29:139–44.CrossRef
17.
go back to reference Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42:878–84.PubMedCrossRef Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42:878–84.PubMedCrossRef
Metadata
Title
Effectiveness of a community pharmacy weight management programme
Authors
Helen F. Boardman
Anthony J. Avery
Publication date
01-08-2014
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 4/2014
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-014-9964-3

Other articles of this Issue 4/2014

International Journal of Clinical Pharmacy 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine